US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Regenerative Medicine: market research reports

Regenerative medicine is an evolving interdisciplinary field of medicine focused on the repair, replacement or regeneration of cells, tissues or organs to restore impaired function resulting from any cause, including disease, trauma, congenital defects and aging. This field holds the promise of using the body’s natural healing process to regenerate damaged tissues and organs, previously irreparable.
Regenerative medicine also allows scientists to use stem cells and nanotechnology to grow tissues and organs in the lab in vitro and implant them into the body.

As the demand for patients requiring organ transplantation is greater than the organs available for donation, regenerative medicine has the potential to solve the problem of organ shortage and save lives. Since the organ’s cells will match those of the patient, organ rejection is not a problem with regenerative medicine. The aim of regenerative medicine is to one day be capable of supporting the body in such a way that there will be no need for organ replacement.

Advances in stem cell science and tissue-engineered scaffolds enable regenerative medicine to be used to repair damaged tissue or organs damaged by aging and disease. Many scientists believe that stem cell treatments have the potential to alleviate suffering and change the face of human disease.

RSS Feeds

Regenerative Medicine market research reports and industry analysis

Regenerative Medicine Market in the US : 2014-2018
6/30/2014 | published by: TechNavio - Infiniti Research Ltd.
... Baxter International Inc., Johnson and Johnson Ltd., Kinetic Concepts Inc., Medtronic Inc., Stryker Corp., Aastrom Biosciences Inc., Acologix Inc., Advanced Cell Technology Inc., Arteriocyte Inc., Athersys Inc.,AvitaMedical Ltd., Bacterin International Inc., Bellicum Pharmaceuticals Inc., Bioactive ...  |  read more...
USD 3,000
Global Regenerative Medicine Market
5/5/2014 | published by: Frost & Sullivan
... the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in ...  |  read more...
USD 4,500
Translational Regenerative Medicine: Market Prospects 2014-2024
11/25/2013 | published by: Visiongain
... 2024, assessing data, trends, opportunities and prospects there. Our study lets you assess regenerative medicine: cell-based therapies that aim to restore function and regenerate diseased tissues. It lets you assess projected sales at world market, ...  |  read more...
USD 2,986
Regenerative Medicine and Stem cells Partnering Terms and Agreements
8/1/2013 | published by: Current Partnering
... companies. Trends in regenerative medicine and stem cells deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells The ...  |  read more...
USD 2,795
The 2013-2018 Outlook for Regenerative Medicine in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
USD 495
The 2013-2018 World Outlook for Regenerative Medicine
7/15/2013 | published by: Icon Group International, Inc.
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly ...  |  read more...
USD 795
Regenerative Medicines: Bone and Joint Applications
6/1/2013 | published by: BCC Research
... tissue damaged by injury, disease, or the aging process. Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018. Coverage of other regenerative applications, ...  |  read more...
USD 6,650
The 2013-2018 Outlook for Regenerative Medicine in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry ...  |  read more...
USD 495
Regenerative Medicine Markets
3/1/2013 | published by: TriMark Publications
... human tissue and organ functions are being made. Whereas before, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself ...  |  read more...
USD 3,400
Perspective: From Promise to Practice — Translational Medicine at the Consumer Doorstep
12/16/2012 | published by: IDC
... today and over the near future. The life science and healthcare ecosystems are increasingly interconnected, which promises to more rapidly and effectively translate discoveries into actionable information for all involved. This new approach is supported ...  |  read more...
USD 1,500
Regenerative Medicine
11/1/2012 | published by: Global Industry Analysts
... 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., Evotec ...  |  read more...
USD 4,950
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications
6/12/2012 | published by: GBI Research
... CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications”, which provides insights into the global regenerative medicine therapeutics market. The report provides an in-depth analysis of regenerative medicine and the challenges in ...  |  read more...
USD 3,500
Global Regenerative Medicine Market
12/1/2011 | published by: RNCOS
... laboratory-grown or therapeutically-induced human tissue as a replacement. After decades of research, many regenerative medicine technologies are in development and approaching commercialization stage, thus leading to the creation of a revenue generating industry. The market, ...  |  read more...
USD 1,200
McGowan Institute for Regenerative Medicine - Product Pipeline Analysis
3/23/2011 | published by: GlobalData
... detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information ...  |  read more...
USD 750
Stem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative Medicine
4/1/2010 | published by: Select Biosciences Limited
... industry participants active in the stem cells field. This bottom-up analysis highlights market trends operative and enables the identification of trends vis-a-vis the research marketplace, utilization of different classes of stem cells, as well as ...  |  read more...
USD 1,618
Autologous Tissue Repair
12/15/2009 | published by: Greystone Research Associates
... on a number of areas, including cardiovascular medicine, refractory wound care, orthopedics, and surgical medicine. The potential economic benefits of autologous tissue repair are significant, as an aging population struggles with intractable ailments that historically ...  |  read more...
USD 2,850
Regenerative Medicines: Bone and Joint Applications
10/1/2009 | published by: BCC Research
... annual growth rate (CAGR) of 8.6%. The largest segment in the market, bone replacement/grafting, was valued at $714 million in 2007. This also has increased only slightly into 2009 but is projected to reach $979 ...  |  read more...
USD 6,650
The 2009-2014 World Outlook for Regenerative Medicine
1/8/2009 | published by: Icon Group International, Inc.
... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ...  |  read more...
USD 795
The 2009 Report on Regenerative Medicine: World Market Segmentation by City
1/5/2009 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...  |  read more...
USD 795
The 2009-2014 Outlook for Regenerative Medicine in India
12/2/2008 | published by: Icon Group International, Inc.
... across over 5,000 cities in India. For each city in question, the percent share the city is of it’s state or union territory and of India as a whole is reported. These comparative benchmarks allow ...  |  read more...
USD 495
The 2009-2014 Outlook for Regenerative Medicine in Japan
12/2/2008 | published by: Icon Group International, Inc.
... 1,000 cities in Japan. For each city in question, the percent share the city is of it’s prefecture and of Japan is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis ...  |  read more...
USD 495
The 2009-2014 Outlook for Regenerative Medicine in Greater China
12/2/2008 | published by: Icon Group International, Inc.
... special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,100 cities in ...  |  read more...
USD 495
The 2009-2014 Outlook for Regenerative Medicine in the United States
12/2/2008 | published by: Icon Group International, Inc.
... across some 12,900 cities in the United States. For each city in question, the percent share the city is of it’s state and of the United States is reported. These comparative benchmarks allow the reader ...  |  read more...
USD 495